Experimental drug safely boosts good cholesterol, lowers bad

American Heart Association Late-Breaking Clinical Trial Report - Abstract: 18597 - EMBARGOED UNTIL 8AM ET November 15, 2011 Study Highlights:In a preliminary trial, an experimental drug safely boosted levels of “good” HDL cholesterol while lowering the “bad” LDL cholesterol associated with the development of clogged arteries.The drug was beneficial alone and in combination with other common cholesterol-lowering drugs called statins.Before becoming available for clinical use, the drug’s safety and effectiveness must be demonstrated in a larger clinical trial.ORLANDO, FLA., Nov. 15, 2011